Overview

Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

Status:
Withdrawn
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The objective is to compare the progression of Atrial Fib (AF) burden by continuous monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation (PVI) versus anti-arrhythmic drug (AAD) therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Valley Health System
Collaborator:
Biosense Webster, Inc.
Treatments:
Anti-Arrhythmia Agents